The practitioner’s role is to care for others, but what happens when they are facing burnout and have no time to care for themselves?
It is a common theme we are hearing from physicians across the specialties we cover.
As the pandemic goes on, the issue of mental health has been coming to the forefront. In her editorial this month, Editor-in-Chief Catherine Y. Spong, MD, gives us a glimpse into her antepartum rounds and the number of women she is seeing who struggle with mental illness and substance abuse.
According to the Centers for Disease Control (CDC), national rates of anxiety have increased four-fold from one year ago. Why wouldn’t that be the case? Life as we know it has been upended. The ability to socialize and the feeling of community has changed, and economic and life stressors are compounded.
In caring for others during this time, physicians also must remember to know their own limits. Last month, we included an article on physician burnout. For ob/gyns, professional organizations such as the American College of Obstetricians and Gynecologists (ACOG) have additional resources.
There are numerous resources available. As Dr. Spong points out, one of her colleagues’ practices has biweekly meetings with a psychologist. These are trying times for everyone. Do not leave yourself out.
Let us know what you are doing for self-care, or what programs are being implemented at your institutions or hospital facilities by emailing Senior Editor Angie DeRosa at aderosa@mjhlifesciences.com.
__
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More